Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy

Hyungjun Kim, Yonghyun Lee, Sukmo Kang, Minsuk Choi, Soyoung Lee, Sunghyun Kim, Vipul Gujrati, Jinjoo Kim, Sangyong Jon

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Self-assembled nanoparticles (NPs) have been intensively utilized as cancer drug delivery carriers because hydrophobic anticancer drugs may be efficiently loaded into the particle cores. In this study, we synthesized and evaluated the therapeutic index of self-assembled NPs chemically conjugated to a fibronectin extra domain B-specific peptide (APTEDB) and an anticancer agent SN38. The APTEDB-SN38 formed self-assembled structures with a diameter of 58 ± 3 nm in an aqueous solution and displayed excellent drug loading, solubility, and stability properties. A pharmacokinetic study revealed that the blood circulation half-life of SN38 following injection of the APTEDB-SN38 NPs was markedly higher than that of the small molecule CPT-11. The APTEDB-SN38 NPs delivered SN38 to tumor sites by both passive and active targeting. Finally, the APTEDB-SN38 NPs exhibited potent antitumor activities and low toxicities against EDB-expressing tumors (LLC, U87MG) in mice. This system merits further preclinical and clinical investigations for SN38 delivery.

Original languageEnglish
Article number48LT01
Issue number48
StatePublished - 2 Nov 2016

Bibliographical note

Publisher Copyright:
© 2016 IOP Publishing Ltd.


  • SN38
  • aptides
  • cancer therapy
  • extra domain B of fibronectin
  • self-assembled nanoparticles


Dive into the research topics of 'Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy'. Together they form a unique fingerprint.

Cite this